Chemours price target lowered to $19 from $23 at Barclays

Barclays lowered the firm’s price target on Chemours (CC) to $19 from $23 and keeps an Equal Weight rating on the shares. The firm thinks new management is executing well to “better re-position and stabilize” Chemours after a volatile 2024. However, difficult end markets and the company’s leverage continue to make the recovery pathway less clear, the analyst tells investors in a research note.